Equities

Jiangsu Yahong Meditech Co Ltd

688176:SHH

Jiangsu Yahong Meditech Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)7.95
  • Today's Change-0.270 / -3.28%
  • Shares traded7.94m
  • 1 Year change-30.45%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jiangsu Yahong Meditech Co Ltd is a China-based company mainly engaged in drug research and development (R&D). The Company focuses on innovative drugs in the field of urogenital tumors and other major diseases. The product pipelines being developed by the Company include APL-1202, APL-1501, APL-1706, APL-1702, ASN-1764, ASN-1780, APL-1901, APL-1401, ASN-1733 and others. The Company is still in the R&D stage.

  • Revenue in CNY (TTM)149.71m
  • Net income in CNY-403.23m
  • Incorporated2010
  • Employees394.00
  • Location
    Jiangsu Yahong Meditech Co LtdRoom 902 Technology BuildingNo.1 Yaocheng AvenueSHANGHAI 200126ChinaCHN
  • Phone+86 2 168585280
  • Fax+86 2 168585281
  • Websitehttps://www.asieris.cn/cn/index.html
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Qingdao Vland Biotech INC1.26bn66.23m3.61bn1.57k54.172.09--2.850.26310.26315.026.830.4253.783.76805,143.803.255.785.097.8944.9846.137.6510.340.924811.630.290433.593.078.0515.56-0.650724.68-6.89
Hinova Pharmaceuticals Inc109.74k-210.18m3.75bn179.00--3.05--34,214.25-2.12-2.120.001112.440.000077.120.0805613.07-14.10-31.86-15.71-37.18-450.31---191,529.30-25,578.246.38--0.0457---100.00--2.44--124.37--
Bide Pharmatech Co Ltd1.10bn80.03m4.04bn846.0049.542.02--3.680.89830.898312.2521.980.46080.93594.511,298,144.003.34--3.82--40.11--7.25--4.59--0.0492--30.94---24.94------
Shanghai Aladdin Biochemical Tech Co Ltd497.71m103.71m4.34bn566.0035.234.17--8.720.44390.44391.983.750.31030.38189.08879,345.607.208.838.229.6161.5761.4923.2126.853.10113.470.278145.716.5519.36-7.489.9531.41--
Jiangsu Yahong Meditech Co Ltd149.71m-403.23m4.53bn394.00--2.18--30.27-0.7074-0.70740.26273.650.059816.646.92379,971.80-16.14-15.80-17.15-16.4878.6355.32-269.87-9,445.918.97--0.0599--52,594.79---62.42--64.28--
Beijing Kawin Technol Sha-hld Co Ltd1.42bn134.34m4.70bn584.0033.632.53--3.310.81750.81758.5310.870.57361.803.272,431,971.006.495.318.526.7681.8086.0211.318.102.91--0.14143.8221.7314.8739.7121.0425.01--
Beijing Sun-Novo Pharma Research Co Ltd1.16bn221.37m5.03bn1.39k22.724.45--4.351.981.9810.3310.100.607935.951.77844,377.1011.2512.9918.7621.7053.3053.9318.5021.341.8629.920.306810.7437.7647.2218.0854.9034.77--
Shanghai Medicilon Inc984.17m-276.79m5.20bn2.42k--2.21--5.28-2.01-2.017.2317.460.30296.901.27378,525.60-8.529.34-10.6611.730.644336.71-28.1214.932.64--0.114720.18-17.6833.26-109.82--23.60--
HitGen Inc423.87m52.55m5.53bn452.00104.994.01--13.050.13140.13141.063.440.2487.104.55937,755.302.994.633.165.1051.2358.8912.0520.6616.1538.230.139119.1412.6419.6961.16-1.96-6.12--
GemPharmatech Co Ltd677.34m139.41m5.62bn1.51k39.942.64--8.290.3430.3431.655.200.27034.542.06449,761.405.569.456.3911.1363.0470.2120.5828.164.74--0.050914.6820.4563.48-3.48--141.38--
InventisBio Co Ltd77.51m-348.02m5.99bn221.00--3.45--77.23-0.6064-0.60640.13463.010.0383--0.5855350,739.20-17.19---18.36--90.80---448.98------0.0138------41.26------
Data as of Nov 14 2024. Currency figures normalised to Jiangsu Yahong Meditech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

3.49%Per cent of shares held by top holders
HolderShares% Held
Penghua Fund Management Co., Ltd.as of 30 Jun 20246.09m2.15%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 20241.68m0.60%
Guotai Asset Management Co., Ltd.as of 30 Jun 2024639.69k0.23%
Guolian Fund Management Co. Ltd.as of 30 Jun 2024506.79k0.18%
Gfund Management Co., Ltd.as of 30 Jun 2024393.77k0.14%
GF Fund Management Co., Ltd.as of 30 Jun 2024156.62k0.06%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 2024118.06k0.04%
Springs Fund Management Co. Ltd.as of 30 Jun 202497.00k0.03%
Yinhua Fund Management Co., Ltd.as of 30 Jun 202492.07k0.03%
China Merchants Fund Management Co., Ltd.as of 30 Jun 202490.36k0.03%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.